OMX Nordic 40
2.332,13
PKT
-9,30
PKT
-0,40
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 18.09.25 | Novo Nordisk Neutral | UBS AG | |
| 18.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.09.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 17.09.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 17.09.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.09.25 | Nokia Underweight | Barclays Capital | |
| 16.09.25 | Novo Nordisk Neutral | UBS AG | |
| 15.09.25 | Novo Nordisk Neutral | UBS AG | |
| 12.09.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 11.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.09.25 | Novo Nordisk Outperform | Bernstein Research | |
| 10.09.25 | Novo Nordisk Neutral | UBS AG | |
| 10.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 09.09.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 08.09.25 | Novo Nordisk Neutral | UBS AG | |
| 08.09.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 08.09.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 08.09.25 | Volvo (B) Neutral | Goldman Sachs Group Inc. | |
| 05.09.25 | Novo Nordisk Neutral | UBS AG | |
| 04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.09.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
| 02.09.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 02.09.25 | Volvo (B) Outperform | RBC Capital Markets | |
| 02.09.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 01.09.25 | Novo Nordisk Neutral | UBS AG | |
| 01.09.25 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.09.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 01.09.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 01.09.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.08.25 | Novo Nordisk Neutral | UBS AG | |
| 29.08.25 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 27.08.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 27.08.25 | AstraZeneca Hold | Deutsche Bank AG | |
| 27.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 27.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 26.08.25 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. |